(Q30583493)

25 June 2017

1 reference

title

Clinical trials with neuroprotective drugs in acute ischaemic stroke: are we doing the right thing? (English)

1 reference

25 June 2017

De Keyser J

1

1 reference

25 June 2017

Sulter G

series ordinal

2

1 reference

25 June 2017

Luiten PG

series ordinal

3

1 reference

25 June 2017

language of work or name

1 reference

1 December 1999

1 reference

25 June 2017

published in

Trends in Neurosciences

1 reference

25 June 2017

volume

22

1 reference

25 June 2017

issue

12

1 reference

25 June 2017

page(s)

535-540

1 reference

Ischemic stroke: treatment on the horizon

25 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901463-0

7 January 2021

Clinical trial of nimodipine in acute ischemic stroke. The American Nimodipine Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901463-0

7 January 2021

A randomized, double-blind, placebo-controlled trial of nimodipine in acute ischemic hemispheric stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901463-0

7 January 2021

Flunarizine in stroke treatment (FIST): a double-blind, placebo-controlled trial in Scandinavia and the Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901463-0

7 January 2021

Termination of Acute Stroke Studies Involving Selfotel Treatment. ASSIST Steering Committed

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901463-0

7 January 2021

Clomethiazole acute stroke study (CLASS): results of a randomized, controlled trial of clomethiazole versus placebo in 1360 acute stroke patients

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901463-0

7 January 2021

Multinational randomised controlled trial of lubeluzole in acute ischaemic stroke. European and Australian Lubeluzole Ischaemic Stroke Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901463-0

7 January 2021

Lubeluzole treatment of acute ischemic stroke. The US and Canadian Lubeluzole Ischemic Stroke Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901463-0

7 January 2021

Ebselen in acute ischemic stroke: a placebo-controlled, double-blind clinical trial. Ebselen Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901463-0

7 January 2021

Early treatment of stroke with monosialoganglioside GM-1. Efficacy and safety results of the Early Stroke Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901463-0

7 January 2021

Ganglioside GM1 in acute ischemic stroke. The SASS Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901463-0

7 January 2021

Citicoline treatment for experimental intracerebral hemorrhage in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901463-0

7 January 2021

Treatment of acute ischemic stroke with piracetam. Members of the Piracetam in Acute Stroke Study (PASS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901463-0

7 January 2021

Comparative study of voltage-sensitive sodium channel blockers in focal ischaemia and electric convulsions in rodents

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901463-0

7 January 2021

Cerestat and other NMDA antagonists in ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901463-0

7 January 2021

The effect of chlormethiazole on neuronal damage in a model of transient focal ischaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901463-0

7 January 2021

The neuroprotective effect of chlormethiazole on ischaemic neuronal damage following permanent middle cerebral artery ischaemia in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901463-0

7 January 2021

Lubeluzole in acute ischemic stroke. A double-blind, placebo-controlled phase II trial. Lubeluzole International Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901463-0

7 January 2021

Clinical trials and financial reimbursement

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901463-0

7 January 2021

Gangliosides. Their role in clinical neurology.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901463-0

7 January 2021

A randomized dose-response trial of citicoline in acute ischemic stroke patients. Citicoline Stroke Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901463-0

7 January 2021

Effects of piracetam on membrane fluidity in the aged mouse, rat, and human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901463-0

7 January 2021

Anti-ICAM-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901463-0

7 January 2021

Animal models of acute ischaemic stroke: can they predict clinically successful neuroprotective drugs?

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901463-0

7 January 2021

Spontaneous reperfusion of cerebral infarcts in patients with acute stroke. Incidence, time course, and clinical outcome in the Copenhagen Stroke Study

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901463-0

7 January 2021

Relation between cerebral blood flow and neurologic deficit resolution in acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901463-0

7 January 2021

Classification and natural history of clinically identifiable subtypes of cerebral infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901463-0

7 January 2021

PET imaging of cerebral perfusion and oxygen consumption in acute ischaemic stroke: relation to outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901463-0

7 January 2021

Regional ischemia and ischemic injury in patients with acute middle cerebral artery stroke as defined by early diffusion-weighted and perfusion-weighted MRI.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901463-0

7 January 2021

Neuroprotection as Initial Therapy in Acute Stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901463-0

7 January 2021

From stroke unit care to stroke care unit

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901463-0

7 January 2021

Hyperthermia nullifies the ameliorating effect of dizocilpine maleate (MK-801) in focal cerebral ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901463-0

7 January 2021

Massive persistent release of excitatory amino acids following human occlusive stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901463-0

7 January 2021

Progressive derangement of periinfarct viable tissue in ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901463-0

7 January 2021

Continuing ischemic damage after acute middle cerebral artery infarction in humans demonstrated by short-echo proton spectroscopy.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901463-0

7 January 2021

Applications of diffusion-perfusion magnetic resonance imaging in acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901463-0

7 January 2021

Prediction of stroke outcome with echoplanar perfusion- and diffusion-weighted MRI

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901463-0

7 January 2021

Diffusion and perfusion MRI, measurements of acute stroke events and outcome: present practice and future hope.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901463-0

7 January 2021

S-100 Protein and Neuron-Specific Enolase Concentrations in Blood as Indicators of Infarction Volume and Prognosis in Acute Ischemic Stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901463-0

7 January 2021

Antipyretics in acute ischaemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901463-0

7 January 2021

Combined neuroprotection and reperfusion therapy for stroke. Effect of lubeluzole and diaspirin cross-linked hemoglobin in experimental focal ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901463-0

7 January 2021

Neuroprotection by excitatory amino acid antagonist augments the benefit of thrombolysis in embolic stroke in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901463-0

7 January 2021

Neuroprotection with NBQX and thrombolysis with rt-PA in rat embolic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901463-0

7 January 2021

bFGF enhances the protective effects of MK-801 against ischemic neuronal injury in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901463-0

7 January 2021

In vivo protection against NMDA-induced neurodegeneration by MK-801 and nimodipine: combined therapy and temporal course of protection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901463-0

7 January 2021

Combination therapy protects ischemic brain in rats. A glutamate antagonist plus a gamma-aminobutyric acid agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901463-0

7 January 2021

Combination therapy with U74006F (tirilazad mesylate), MK-801, insulin and diazepam in transient forebrain ischaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901463-0

7 January 2021

Synergistic effects of citicoline and MK-801 in temporary experimental focal ischemia in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901463-0

7 January 2021

Tissue plasminogen activator for acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901463-0

7 January 2021

ECASS-II: intravenous alteplase in acute ischaemic stroke. European Co-operative Acute Stroke Study-II

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901463-0

7 January 2021

10.1016/S0166-2236(99)01463-0

Identifiers

DOI

1 reference

25 June 2017

1 reference